Neoleukin Therapeutics Inc (NASDAQ:NLTX)
| 0.685 Delayed Data As of Mar 31 |  -0.01 / -1.44%Today’s Change | 0.38 Today|||52-Week Range 2.32 | +34.58% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Operating Expenses | Gross Income | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| General Expenses | 6.7M | 4.3M | 2.4M | 2.2M | ||
| Research And Development | 2.8M | 1.5M | 4.0K | 5.0K | ||
| Total Operating Expenses | 6.7M | 4.3M | 2.4M | 2.2M | ||
| Non-Operating Expenses | Operating Income | -6.7M | -4.3M | -2.4M | -2.2M | |
| Extraordinary Credit | 0.00 | 0.00 | 0.00 | 1.8M | ||
| Extraordinary Charge | -9.0M | -1.4M | -300.0K | -- | ||
| Interest Expense On Debt | 0.00 | 4.0K | -- | 0.00 | ||
| Other Expenses | 235.0K | 347.0K | 1.0K | -9.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -15.0M | -4.9M | -2.2M | -1.0K | |
| Net Income | -15.0M | -4.9M | -2.2M | -1.0K | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 23.5M | 23.5M | 23.5M | 23.5M | |
| Shares To Calculate EPS Diluted | 23.5M | 23.5M | 23.5M | 23.5M | ||
| Earnings Per Share | EPS | -$0.64 | -$0.20 | -$0.09 | $0.00 | |
| EPS Diluted | -$0.64 | -$0.21 | -$0.09 | $0.00 | ||
